Max Ruzanov

846 total citations
4 papers, 23 citations indexed

About

Max Ruzanov is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Max Ruzanov has authored 4 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Molecular Biology and 1 paper in Infectious Diseases. Recurrent topics in Max Ruzanov's work include Inflammatory mediators and NSAID effects (1 paper), interferon and immune responses (1 paper) and Protein Tyrosine Phosphatases (1 paper). Max Ruzanov is often cited by papers focused on Inflammatory mediators and NSAID effects (1 paper), interferon and immune responses (1 paper) and Protein Tyrosine Phosphatases (1 paper). Max Ruzanov collaborates with scholars based in United States, Germany and India. Max Ruzanov's co-authors include J.K. Muckelbauer, S. Sheriff, Daša Lipovšek, John A. Newitt, Bradley C. Pearce, Mian Gao, Dianlin Xie, Frank Marsilio, ChiehYing Y. Chang and Wai Leung Lau and has published in prestigious journals such as Nature Communications, Bioorganic & Medicinal Chemistry Letters and Journal of Biomolecular Structure and Dynamics.

In The Last Decade

Max Ruzanov

4 papers receiving 22 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Ruzanov United States	3	16	9	5	2	2	4	23
Tim Mandelkow Germany	2	12 0.8×	7 0.8×	5 1.0×	2 1.0×		6	15
Daisy D. Colón-López United States	3	19 1.2×	5 0.6×	4 0.8×	1 0.5×	2 1.0×	4	32
Yohana Ghebrechristos United States	2	16 1.0×	15 1.7×	3 0.6×	2 1.0×	4 2.0×	3	28
Tanisha Meeuwsen United States	3	13 0.8×	12 1.3×	5 1.0×	2 1.0×		3	26
Jasmine T. Tran United States	2	16 1.0×	12 1.3×	8 1.6×		1 0.5×	7	37
Rick Stanton United States	4	26 1.6×	7 0.8×	7 1.4×	2 1.0×		5	38
Elizabeth Martínez‐Pérez Argentina	3	14 0.9×	7 0.8×	4 0.8×	1 0.5×		4	19
Abby Marquez	3	31 1.9×	18 2.0×	6 1.2×		1 0.5×	5	37
Minyue Chen United States	4	18 1.1×	13 1.4×	4 0.8×	4 2.0×	4 2.0×	5	39
Ariana Hardy United States	2	15 0.9×	6 0.7×	4 0.8×	1 0.5×		4	29

Countries citing papers authored by Max Ruzanov

Since Specialization

Citations

This map shows the geographic impact of Max Ruzanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Ruzanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Ruzanov more than expected).

Fields of papers citing papers by Max Ruzanov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Ruzanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Ruzanov. The network helps show where Max Ruzanov may publish in the future.

Co-authorship network of co-authors of Max Ruzanov

This figure shows the co-authorship network connecting the top 25 collaborators of Max Ruzanov. A scholar is included among the top collaborators of Max Ruzanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Ruzanov. Max Ruzanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Xie, Tao, Max Ruzanov, David Critton, et al.. (2025). Orthosteric STING inhibition elucidates molecular correction of SAVI STING. Nature Communications. 16(1). 5695–5695. 2 indexed citations

2.

Battaile, K.P., Н. К. Балабаев, V. Romanov, et al.. (2021). Signal transfer in human protein tyrosine phosphatase PTP1B from allosteric inhibitor P00058. Journal of Biomolecular Structure and Dynamics. 40(24). 13823–13832. 6 indexed citations

3.

Lau, Wai Leung, Bradley C. Pearce, Dianlin Xie, et al.. (2020). Using yeast surface display to engineer a soluble and crystallizable construct of hematopoietic progenitor kinase 1 (HPK1). Acta Crystallographica Section F Structural Biology Communications. 77(1). 22–28. 11 indexed citations

4.

Duan, James J.‐W., Bin Jiang, Zhonghui Lu, et al.. (2020). Discovery of 2,6–difluorobenzyl ether series of phenyl ((R)–3–phenylpyrrolidin–3–yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists. Bioorganic & Medicinal Chemistry Letters. 30(19). 127441–127441. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact